Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and Definitions
Mayo Clinic · Mayo Clinic in Florida · +49 more institutions
Abstract
Epilepsy syndromes have been recognized for >50 years, as distinct electroclinical phenotypes with therapeutic and prognostic implications. Nonetheless, no formally accepted International League Against Epilepsy (ILAE) classification of epilepsy syndromes has existed. The ILAE Task Force on Nosology and Definitions was established to reach consensus regarding which entities fulfilled criteria for an epilepsy syndrome and to provide definitions for each syndrome. We defined an epilepsy syndrome as "a characteristic cluster of clinical and electroencephalographic features, often supported by specific etiological findings (structural, genetic, metabolic, immune, and infectious)." The diagnosis of a syndrome in an…
Citation impact
- FWCI
- 34.28
- Percentile
- 100%
- References
- 32
Authors
22- EWElaine WirrellCorresponding
Mayo Clinic, Mayo Clinic in Florida
- RNRima Nabbout
European Organisation for Rare Diseases, Université Paris Cité, Institut des Maladies Génétiques Imagine
- IEIngrid E. Scheffer
Royal Children's Hospital, Florey Institute of Neuroscience and Mental Health, Murdoch Children's Research Institute
- TATaoufik Alsaadi
Emirates Foundation
- ABAlicia Bogacz
Universidad de la República de Uruguay, Hospital de Clínicas, Universidad de Montevideo
Topics & keywords
- Nosology
- Epilepsy
- Epilepsy syndromes
- Etiology
- Psychogenic disease
- Psychology
- Medicine
- Psychiatry
Funding
- UDU.S. Department of DefenseAwards: W81XWH, W81XWH-18, W81XWH-18-1-0612
- ELEli Lilly and Company
- PPfizer
- GGlaxoSmithKline
- SSanofi
- BBiogen
- GHGenomic Health
- UOUniversity of Calgary
- MMedicure
- SSunovion
- VVitaflo
- WFWaterloo Foundation
- ZZogenix
- UPUltragenyx Pharmaceutical
- LLivaNova
- GPGW Pharmaceuticals
- ZPZynerba Pharmaceuticals
- MPMarinus Pharmaceuticals
- SLSK Life Science
- UUpsher-Smith
- NINational Institute for Health and Care Research
- EREpilepsy Research UK
- TTenovus
- ECEuropean Commission
- GOGreat Ormond Street Hospital Charity
- ASAustrian Science Fund
- EEisai
- BFBundesministerium für Wissenschaft und Forschung
- ENEVER Neuro Pharma
- AIAlberta Innovates
- GPG.L. Pharma
- HLH. Lundbeck A/S
- EEpilepsiatutkimussäätiö
- ATArvelle Therapeutics
- SSeqirus
- NINational Institutes of HealthAwards: U54 NS100064, NS100064, W81XWH, NS43209
- CSCumming School of Medicine, University of Calgary
- CICanadian Institutes of Health Research
- MRMedical Research CouncilAward: U54 NS100064
- EAEngineering and Physical Sciences Research Council
- NHNational Health and Medical Research Council
- GOGreat Ormond Street Institute of Child Health
- NINational Institute of Neurological Disorders and StrokeAwards: U54 NS100064, NS43209, NS100064
- UPUCB Pharma
- CCilag